Table 3.
Infant characteristics at enrolment
| Standard (n=29) n (%)* |
Restrictive (n=29) n (%)* |
|
| Received respiratory support | 29 (100) | 29 (100) |
| Supplemental oxygen | 25 (86) | 23 (79) |
| CPAP | 3 (10) | 5 (17) |
| Conventional ventilation | 24 (83) | 23 (79) |
| High-frequency ventilation | 2 (7) | 2 (7) |
| Respiratory distress syndrome | 25 (86) | 27 (93) |
| Surfactant first given in the delivery room | 17 (59) | 19 (66) |
| Surfactant first given in the NICU | 10 (34) | 9 (31) |
| Not given | 2 (7) | 1 (3) |
| Pneumothorax | 0 (0) | 2 (7) |
| Inhaled nitric oxide | 1 (3) | 2 (7) |
| Patien uctus rteriosu on echo | 5 (17) | 6 (21) |
| Indomethacin for prophylaxis | 0 (0) | 1 (3) |
| Indomethacin for PDA | 0 (0) | 0 (0) |
| Ibuprofen for PDA | 1 (3) | 0 (0) |
| Pulmonary haemorrhage | 1 (3) | 0 (0) |
| Lowest recorded MABP (mm Hg), median (IQR) | 21.0 (20.0–23.0) | 22.0 (19.5–23.5) |
| Mean (SD) mm Hg BP<GA | 3.6 (2.1) | 3.5 (1.9) |
| Lactate (mmol/L), median (IQR)† | 1.9 (1.2–3.1) | 2.2 (1.6–4.6) |
*Unless otherwise stated.
†n=27 in the standard group.
BP, blood pressure; CPAP, continuous positive airway pressure; GA, gestational age; MABP, mean arterial blood pressure; NICU, neonatal intensive care unit; PDA, patent ductus arteriosus.